Monosaccharides

1,2,3,4-Tetra-O-acetyl-6-O-(tert-butyldimethylsilyl)-a-D-mannopyranose is a synthetic sugar that is used in the synthesis of glycosylations. It has been shown to be a substrate for methylation and click modification. This product is also useful in the synthesis of oligosaccharides and polysaccharides. 1,2,3,4-Tetra-O-acetyl-6-O-(tert-butyldimethylsilyl)-a-D-mannopyranose is a high purity carbohydrate with a CAS number.

Benzyl 2-acetamido-6-O-benzoyl-2-deoxy-a-D-muramic acid methyl ester is a high purity, custom synthesis, monosaccharide that can be used to modify saccharides and oligosaccharides. It has been shown to be effective in glycosylation reactions and click chemistry. The CAS number for this compound is 84778-00-3.

2-Acetamido-2-deoxy-b-D-galactopyranosyl serine is a glycosylation agent that can be used as a sugar donor in glycoprotein synthesis. This product is available as custom synthesis and has been modified with fluorination, saccharide, and modification. It also has CAS number: 3897-78-5. 2 Acetamido-2 deoxy b D galactopyranosyl serine is a monosaccharide that is synthesized from D galactose and L serine. It can be used to produce complex carbohydrates for Methylations, Click modifications, Polysaccharides, or Fluorinations.

2,3,4-Tri-O-acetyl-b-L-fucopyranosyl dibenzyl phosphate is a fluorinated carbohydrate that can be custom synthesized to order. The compound is a modification of the pentose sugar, D-ribose and contains an acetyl group at C2' position of the sugar. The compound has been shown to have anti-inflammatory activities in rats.

UDP-D-galactosamine disodium salt is a type of sugar that is a substrate for UDP-glucuronosyltransferase (UGT), which catalyzes the transfer of galactose from UDP-D-galactose to other molecules. The product of this reaction is UDP-D-galacturonic acid. It is produced in the liver, where it participates in the synthesis of glycoproteins, glycolipids, and glycosaminoglycans. In addition, it can be found in the distal tubule of the kidney and in leukemia cells. The histological analysis of rat liver tissue showed that UDP-D-galactosamine disodium salt is present in hepatocytes. This sugar also helps with protein synthesis and activates uridine, which can be used as a carbon source. Histological analysis also revealed that UDP-D-galactosamine disodium salt plays an important role in glucose metabolism, as well as

Inhibitor of lysosomal acid β-glucosidase (GlcCerase/glucocerebrosidase) with IC50 in nanomolar range for wildtype and mutant enzyme. It behaves as pharmacological chaperon by binding to instable GlcCerase active site at neutral pH values and facilitating the protein folding. In acidic lysosomes, isofagomine gets release from the enzyme active site. This results in increased levels of functional glucocerebrosidase and brings therapeutic benefits to patients with Gaucher disease.

4,7,8,9-Tetra-O-acetyl-N-acetyl-D-neuraminic acid methyl ester is a modified form of sialic acid. This compound is a glycosylation product that has been modified with methyl groups and fluorine atoms. The fluorination of the molecule increases its stability and prevents it from being hydrolyzed by enzymes such as β-galactosidase. 4,7,8,9-Tetra-O-acetyl-N-acetyl-D-neuraminic acid methyl ester is often used in the synthesis of polysaccharides and oligosaccharides for medical purposes. This compound can be custom synthesized for research purposes or to meet special requirements.

L-altronojirimycin is a diterpene glycoside that belongs to the group of natural products that have inhibitory properties against lipid peroxidation. It has been shown to decrease the concentration of 1,2-dipalmitoylglycerophosphocholine (DPPC) in primary cells and reduce the rate of lipid peroxidation in a concentration-dependent manner. L-altronojirimycin inhibits the activity of enzymes such as acetylcholinesterase and phospholipase A2, which are involved in inflammation. This drug has also been shown to have cardioprotective effects and inhibit mutations in cardiac muscle cells. L-altronojirimycin has been tested for its long-term efficacy and shown to be effective against both bowel disease and cardiac effects.

(R)-Ketoprofen b-D-glucuronide is a synthetic modified sugar that is produced by the glucuronidation of ketoprofen, a nonsteroidal anti-inflammatory drug. The modification of ketoprofen with glucuronic acid can be achieved through an enzymatic process, which is catalyzed by UDP-glucuronyltransferase. This modification increases the solubility of ketoprofen and its ability to penetrate cells. (R)-Ketoprofen b-D-glucuronide has been shown to have antibacterial properties against Gram positive bacteria such as Staphylococcus aureus and Streptococcus pyogenes. It has also shown antiviral activity against HIV-1 due to its inhibition of reverse transcriptase, which is an enzyme important for viral replication.